171 results
8-K
EX-10.1
FRTX
Fresh Tracks Therapeutics, Inc.
7 Mar 24
Termination of a Material Definitive Agreement
8:44am
8-K
EX-10.2
FRTX
Fresh Tracks Therapeutics, Inc.
10 Oct 23
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
gxczv5np4s
10 Oct 23
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
5edme8
21 Jul 23
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix
8:02am
8-K
EX-10.2
86hkwzkyq7
21 Jul 23
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix
8:02am
8-K
EX-10.2
bfrssivxc
24 Feb 23
Departure of Directors or Certain Officers
4:12pm
8-K
EX-10.3
s5mjmtav
24 Feb 23
Departure of Directors or Certain Officers
4:12pm
8-K
EX-10.1
mesrzraq5cwc
24 Feb 23
Departure of Directors or Certain Officers
4:12pm
8-K/A
EX-10.1
ghceqap4tomx8snfdwma
22 Feb 23
Departure of Directors or Certain Officers
4:04pm
8-K
EX-10.1
ao4a4j
7 Feb 23
Departure of Directors or Certain Officers
5:05pm
8-K
EX-10.1
ze2mt72n
27 Jan 23
Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief Executive Officer
4:06pm